WHO ICTRP trial
A study of mepolizumab (study medication) as add-on therapy in subjects who…
EUCTR2012-001497-29-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-001497-29-GB |
|---|---|
| Public title | A study of mepolizumab (study medication) as add-on therapy in subjects who require daily oral corticosteroids to treat their severe asthma |
| Scientific title | MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects with Severe Refractory Asthma |
| Primary sponsor | GlaxoSmithKline Research and Development Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United States;Mexico;Canada;Australia;Netherlands;Germany;United Kingdom |
| Conditions | Severe asthma MedDRA version: 14.1 Level: PT Classification code 10003553 Term: Asthma System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] |
| Interventions | Product Name: Mepolizumab Product Code: SB-240563 Pharmaceutical Form: Lyophilisate for solution for injection INN or Proposed INN: MEPOLIZUMAB CAS Number: 196078-29-2 Current Sponsor code: SB-240563 Other descriptive name: MEPOLIZUMAB… |
| Registration date | Dec 7, 2012 |
| Target size | 120 |
| Secondary IDs | MEA115575 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: